Difference between revisions of "Structure-based mutation analysis GLA"
m (→M42T (Mutation 1)) |
(→Visual Examination of the Mutations) |
||
Line 176: | Line 176: | ||
Serine is hydrophilic and the residue is exposed on the surface, but threonine is also a hydrophilic residue. There is no remarkable change of the surface of the protein. |
Serine is hydrophilic and the residue is exposed on the surface, but threonine is also a hydrophilic residue. There is no remarkable change of the surface of the protein. |
||
+ | {| border="0" style="text-align:center; border-spacing:0" cellpadding="2" cellspacing="3" align = "center" |
||
− | {| align="centered" |
||
| [[Image:Fabry_Disease_1R47_res65_wt.png|thumb|150px|Figure 6: Close-up of serine (wildtype) at position 65 in the protein GLA.]] |
| [[Image:Fabry_Disease_1R47_res65_wt.png|thumb|150px|Figure 6: Close-up of serine (wildtype) at position 65 in the protein GLA.]] |
||
| [[Image:Fabry_Disease_1R47_res65_mut.png|thumb|150px|Figure 7: Close-up of threonine (mutated) at position 65 in the protein GLA. The side chain conformation was done manually.]] |
| [[Image:Fabry_Disease_1R47_res65_mut.png|thumb|150px|Figure 7: Close-up of threonine (mutated) at position 65 in the protein GLA. The side chain conformation was done manually.]] |
||
Line 183: | Line 183: | ||
===I117S (Mutation 3)=== |
===I117S (Mutation 3)=== |
||
+ | {| border="0" style="text-align:center; border-spacing:0" cellpadding="2" cellspacing="3" align = "center" |
||
− | {| align="centered" |
||
| [[Image:Fabry_Disease_1R47_res117_wt.png|thumb|100px|Close-up of the wildtype residue number 117 of GLA.]] |
| [[Image:Fabry_Disease_1R47_res117_wt.png|thumb|100px|Close-up of the wildtype residue number 117 of GLA.]] |
||
| [[Image:Fabry_Disease_1R47_res117_mut.png|thumb|100px|Close-up of the mutated residue number 117 of GLA.]] |
| [[Image:Fabry_Disease_1R47_res117_mut.png|thumb|100px|Close-up of the mutated residue number 117 of GLA.]] |
||
Line 190: | Line 190: | ||
===A143T (Mutation 4)=== |
===A143T (Mutation 4)=== |
||
+ | {| border="0" style="text-align:center; border-spacing:0" cellpadding="2" cellspacing="3" align = "center" |
||
− | {| align="centered" |
||
| [[Image:Fabry_Disease_1R47_res143_wt.png|thumb|100px|Close-up of the wildtype residue number 143 of GLA.]] |
| [[Image:Fabry_Disease_1R47_res143_wt.png|thumb|100px|Close-up of the wildtype residue number 143 of GLA.]] |
||
| [[Image:Fabry_Disease_1R47_res143_mut.png|thumb|100px|Close-up of the mutated residue number 143 of GLA.]] |
| [[Image:Fabry_Disease_1R47_res143_mut.png|thumb|100px|Close-up of the mutated residue number 143 of GLA.]] |
||
Line 197: | Line 197: | ||
===H186R (Mutation 5)=== |
===H186R (Mutation 5)=== |
||
+ | {| border="0" style="text-align:center; border-spacing:0" cellpadding="2" cellspacing="3" align = "center" |
||
− | {| align="centered" |
||
| [[Image:Fabry_Disease_1R47_res186_wt.png|thumb|100px|Close-up of the wildtype residue number 186 of GLA.]] |
| [[Image:Fabry_Disease_1R47_res186_wt.png|thumb|100px|Close-up of the wildtype residue number 186 of GLA.]] |
||
| [[Image:Fabry_Disease_1R47_res186_mut.png|thumb|100px|Close-up of the mutated residue number 186 of GLA.]] |
| [[Image:Fabry_Disease_1R47_res186_mut.png|thumb|100px|Close-up of the mutated residue number 186 of GLA.]] |
||
Line 204: | Line 204: | ||
===P205T (Mutation 6)=== |
===P205T (Mutation 6)=== |
||
+ | {| border="0" style="text-align:center; border-spacing:0" cellpadding="2" cellspacing="3" align = "center" |
||
− | {| align="centered" |
||
| [[Image:Fabry_Disease_1R47_res205_wt.png|thumb|100px|Close-up of the wildtype residue number 205 of GLA.]] |
| [[Image:Fabry_Disease_1R47_res205_wt.png|thumb|100px|Close-up of the wildtype residue number 205 of GLA.]] |
||
| [[Image:Fabry_Disease_1R47_res205_mut.png|thumb|100px|Close-up of the mutated residue number 205 of GLA.]] |
| [[Image:Fabry_Disease_1R47_res205_mut.png|thumb|100px|Close-up of the mutated residue number 205 of GLA.]] |
||
Line 211: | Line 211: | ||
===D244H (Mutation 7)=== |
===D244H (Mutation 7)=== |
||
+ | {| border="0" style="text-align:center; border-spacing:0" cellpadding="2" cellspacing="3" align = "center" |
||
− | {| align="centered" |
||
| [[Image:Fabry_Disease_1R47_res244_wt.png|thumb|100px|Close-up of the wildtype residue number 244 of GLA.]] |
| [[Image:Fabry_Disease_1R47_res244_wt.png|thumb|100px|Close-up of the wildtype residue number 244 of GLA.]] |
||
| [[Image:Fabry_Disease_1R47_res244_mut.png|thumb|100px|Close-up of the mutated residue number 244 of GLA.]] |
| [[Image:Fabry_Disease_1R47_res244_mut.png|thumb|100px|Close-up of the mutated residue number 244 of GLA.]] |
||
Line 218: | Line 218: | ||
===Q283P (Mutation 8)=== |
===Q283P (Mutation 8)=== |
||
+ | {| border="0" style="text-align:center; border-spacing:0" cellpadding="2" cellspacing="3" align = "center" |
||
− | {| align="centered" |
||
| [[Image:Fabry_Disease_1R47_res283_wt.png|thumb|100px|Close-up of the wildtype residue number 283 of GLA.]] |
| [[Image:Fabry_Disease_1R47_res283_wt.png|thumb|100px|Close-up of the wildtype residue number 283 of GLA.]] |
||
| [[Image:Fabry_Disease_1R47_res283_mut.png|thumb|100px|Close-up of the mutated residue number 283 of GLA.]] |
| [[Image:Fabry_Disease_1R47_res283_mut.png|thumb|100px|Close-up of the mutated residue number 283 of GLA.]] |
||
Line 224: | Line 224: | ||
|} |
|} |
||
===Q321E (Mutation 9)=== |
===Q321E (Mutation 9)=== |
||
+ | {| border="0" style="text-align:center; border-spacing:0" cellpadding="2" cellspacing="3" align = "center" |
||
− | {| align="centered" |
||
| [[Image:Fabry_Disease_1R47_res321_wt.png|thumb|100px|Close-up of the wildtype residue number 321 of GLA.]] |
| [[Image:Fabry_Disease_1R47_res321_wt.png|thumb|100px|Close-up of the wildtype residue number 321 of GLA.]] |
||
| [[Image:Fabry_Disease_1R47_res321_mut.png|thumb|100px|Close-up of the mutated residue number 321 of GLA.]] |
| [[Image:Fabry_Disease_1R47_res321_mut.png|thumb|100px|Close-up of the mutated residue number 321 of GLA.]] |
||
Line 231: | Line 231: | ||
===R363C (Mutation 10)=== |
===R363C (Mutation 10)=== |
||
+ | {| border="0" style="text-align:center; border-spacing:0" cellpadding="2" cellspacing="3" align = "center" |
||
− | {| align="centered" |
||
| [[Image:Fabry_Disease_1R47_res363_wt.png|thumb|100px|Close-up of the wildtype residue number 363 of GLA.]] |
| [[Image:Fabry_Disease_1R47_res363_wt.png|thumb|100px|Close-up of the wildtype residue number 363 of GLA.]] |
||
| [[Image:Fabry_Disease_1R47_res363_mut.png|thumb|100px|Close-up of the mutated residue number 363 of GLA.]] |
| [[Image:Fabry_Disease_1R47_res363_mut.png|thumb|100px|Close-up of the mutated residue number 363 of GLA.]] |
Revision as of 01:40, 5 September 2011
by Benjamin Drexler and Fabian Grandke
Contents
Introduction
In this task we analyse the structure of our protein to find out what effects the point mutations have. Therefore we created mutated structures and compared them to the wild-type protein. Several tools based on different methods have been used to achieve that aim. We used the mutations that we have chosen in the previous task.
Methods
In the first step of this task we had to find available protein structures for our protein and to decide which one would be the best for our detailed analysis. We set several cut-offs to exclude improper structures. The following tools have been used to perform the energy calulations. They were used as described in the task description.
SCWRL
SCWRL was initially developed by Dunbrack et al. in 1997. We use SCWRL4<ref name=dunb>G. G. Krivov, M. V. Shapovalov, and R. L. Dunbrack, Jr. Improved prediction of protein side-chain conformations with SCWRL4. Proteins (2009)</ref> which was published in 2009. The program takes a PDB file and a sequence file as input. By usage of a rotamer library, collision detection, and a residue interaction graph the optimal side-chain conformation is calculated, based on the backbone and the mutated sequence given in the input files. The output is a PDB file containing the conformation and the total minimal energy of the graph in STDOUT.
FoldX
FoldX was developed by Serrano et al. in 2002<ref name=serr>Guerois R, Nielsen JE, Serrano L., Predicting Changes in the Stability of Proteins and Protein Complexes: A Study of More Than 1000 Mutation. Journal of Molecular Biology (2002)</ref>. We used version FoldX 3.0 beta 4. The program provides the calculation of determination of energy effects of point mutations. It provides different run modes, but basically it takes a PDB file as input calculates several single energies(e.g. Van der Waals, Electrostatics, ...) and returns the single energies together with the total energy as output.
Minimise
Before this tool from the virtual box was used we had to remove the hydrogens and waters from the PDB file with the script repairPDB. Afterwards we were able to compare the energies differences between the wildtype and the mutated protein.
GROMACS
GROMACS is mostly a package to perform molecular dynamics, but it also provides energy calculations.
For the mutations we used the forcefield AMBER03 and for the wildtype AMBER03, AMBERGS and CHARMM27.
Additionally to the energy calculation task we did a runtime analysis with values from nsteps=10 to nsteps=1500. The results are shown in the results section of this task.
According to the task description we created an MDP file with the following content:
title = PBSA minimization in vacuum
cpp = /usr/bin/cpp
define = -DFLEXIBLE -DPOSRES
implicit_solvent = GBSA
integrator = steep
emtol = 1.0
nsteps = 500
nstenergy = 1
energygrps = System
ns_type = grid
coulombtype = cut-off
rcoulomb = 1.0
rvdw = 1.0
constraints = none
pbc = no
Keyword | Describtion<ref name=manual>Gromacs Manual</ref> |
---|---|
General | |
title | Name of Project |
cpp | Location of c-preprocessor |
Preprocessing | |
define | Defines to pass to the preprocessor; -DFLEXIBLE:include flexible water in stead of rigid water into your topology; -DPOSRES: include posre.itp into your topology, used for position restraints |
Implicit Solvent | |
implicit_solvent | Simulation with implicit solvent using the Generalized Born formalism |
Run Control | |
integrator | Steepest descent algorithm for energy minimization |
nsteps | Maximum number of steps to integrate or minimize |
Energy minimization | |
emtol | Rhe minimization is converged when the maximum force is smaller than this value |
Output | |
nstenergy | Frequency to write energies to energy file |
Tables | |
energygrps | Group(s) to write to energy file |
Neighbor searching | |
ns_type | Type of neighbor searching |
pbc | Remove the periodicity (make molecule whole again) |
Electrostatics | |
coulombtype | Type of coulomb energy |
rcoulomb | Distance for the Coulomb cut-off |
VDW | |
rvdw | distance for the LJ or Buckingham cut-off |
Bonds | |
constraints | Which constraints should be used |
Within the GROMACS work step we used the script fetchpdb. It checks if the given input is a valid PDB entry. If the check was successful it downloads the PDB file, extracts it and removes the packed version.
Results
Structure Selection
There are several structure files available for our protein:
PDB ID | Resolution [Å] | ph-Value | R-Factor | Coverage [%] | Missing Residues |
---|---|---|---|---|---|
1R46 | 3.25 | 8.0 | 0.262 | 99.7 | 422-429 |
1R47 | 3.45 | 8.0 | 0.285 | 99.5 | 422-429 |
3GXN | 3.01 | NULL | 0.239 | 88.08 | 422-429 |
3GXP | 2.20 | NULL | 0.204 | 81.9 | 422-429 |
3GXT | 2.70 | NULL | 0.245 | 97.29 | 422-429 |
3HG2 | 2.30 | 4.6 | 0.178 | 97.32 | 422-429 |
3HG3 | 1.90 | 6.5 | 0.167 | 98.64 | 427-435 |
3HG4 | 2.30 | 4.6 | 0.166 | 99.86 | 422-429 |
3HG5 | 2.30 | 4.6 | 0.192 | 100 | 422-429 |
3LX9 | 2.04 | 6.5 | 0.178 | 98.92 | 423-435 |
3LXA | 3.04 | 6.5 | 0.216 | 99.52 | 427-435 |
3LXB | 2.85 | 6.5 | 0.227 | 99.3 | 427-435 |
3LXC | 2.35 | 6.5 | 0.186 | 98.31 | 423-435 |
We set two cutoffs to decide which structures are excluded:
- ph-value: < 6.5
- resolution: > 2.7
After we applied the cutoffs to our set of structures three were left (exclusion factors are colored red in the table). One of them was slightly better than the other ones so we decided to use 3HG3 (worse values are colored gray in the table). Additionally 3GH3 has the best overall resolution and R-factor (colored green). As the missing residues are very similar for all structures they are not further taken into account.
Visual Examination of the Mutations
Figure 1 shows the protein α-galactosidase A and the residues which will be mutated. In the following sections, we compare the side chain conformation of the mutated residues and discuss the influence of the mutation. Aspects will be, inter alia, loss of polar interactions and clashes with other residues.
SCWRL was used to model the side chain conformation of the mutated residue and we use the term tool-based to describe this side chain conformation. The side chain conformation which was done according to this tutorial is referred to as manual side chain conformation.
- close to active site?
- comparison of side chain conformation
- clashes?
- polar interactions
- hydrophobic/hydrophilic?
- surface
M42T (Mutation 1)
Figures 2 to 4 show the side chain conformation of the residue 42 in α-galactosidase A. The only difference between the manual and the tool-based side chain conformation is a variation in the conformation of the hydroxyl group of threonine (see figure 3 and 4). The tool-based side chain conformation does not lead to any clashes with the surrounding residues.
The wildtype M42 has two hydrogen bonds with E87 and Y88. Since these hydrogen bonds are formed by the carboxylgroup of the backbone, they are also abundant in the mutation, but T42 also forms a hydrogen bond with G85.
A part of T42 is exposed to the surface (see figure 5B). This is no problem, since threonine is slightly hydrophilic. But the mutation introduces a small hole into the surface of GLA (see figure 5A and 5B).
S65T (Mutation 2)
The side chain conformation of the wildtype and the mutated residues is shown in figure 6 to 8. The hydroxyl and methyl group of threonine point towards totally different direction in the tool-based conformation (see figure 6 and 8), but there are no clashes with other residues. The wildtype S65 forms five hydrogen bonds with surrounding residues (C63, K67, L68, F69). The mutated residue T65 forms also five hydrogen bonds, but one of them is with E66 instead of K67.
Serine is hydrophilic and the residue is exposed on the surface, but threonine is also a hydrophilic residue. There is no remarkable change of the surface of the protein.
I117S (Mutation 3)
A143T (Mutation 4)
H186R (Mutation 5)
P205T (Mutation 6)
D244H (Mutation 7)
Q283P (Mutation 8)
Q321E (Mutation 9)
R363C (Mutation 10)
Energy Comparison
The results of the energy comparison are presented in the table below. Due to the fact that the result of the first run of the eighth mutation clearly differed from the other results, the run was repeated with the outcome from the first run as input. Thus, there is the number 8.2. This observation shows that minimise has a decreased tolerance for clashes in comparison to the other tools. Their results for the eighth run are not outstanding and seem not to be affected by the fact that a proline was inserted into a helix. Furthermore, their results seem to be almost equally with respect to some variance. Only the comparison of the FoldX results of the mutations with the wildtype show, that the inserted mutations have a huge influence on the energy of the protein.
Number | AA-Position | Codon change | Amino acid change | SCWRL4 | FoldX | FoldX - Diff | Minimise | Minimise - Diff |
---|---|---|---|---|---|---|---|---|
WT | - | -20.93 | - | -20481.23 | - | |||
1 | 42 | ATG-ACG | Met -> Thr | 343.25 | 157.29 | -178.22 | -20324.41 | -156.82 |
2 | 65 | AGT-ACG | Ser -> Thr | 327.798 | 152.87 | -173.8 | -20339.34 | -141.89 |
3 | 117 | ATT-AGT | Ile -> Ser | 333.027 | 157.97 | -178.9 | -20353.47 | -127.76 |
4 | 143 | cGCA-ACA | Ala -> Thr | 333.944 | 154.40 | -175.33 | -20339.32 | -141.91 |
5 | 186 | CAC-CGC | His -> Arg | 323.717 | 154.57 | -175.5 | -20321.32 | -159.91 |
6 | 205 | gCCT-ACT | Pro -> Thr | 340.619 | 155.96 | -176.89 | -20345.87 | -135.36 |
7 | 244 | gGAC-CAC | Asp -> His | 333.594 | 152.08 | -173.01 | -20393.12 | -88.11 |
8 | 283 | CAG-CCG | Gln -> Pro | 332.631 | 159.91 | -180.84 | -8027.71 | -12453.52 |
8.2 | - | - | - | - | - | - | -19134.48 | -1346,95 |
9 | 321 | tCAG-TAG | Gln -> Glu | 332.853 | 160.95 | -181.88 | -20246.98 | -234.25 |
10 | 363 | TATa-TAA | Arg -> Cys | 330.56 | 150.50 | -171.43 | -20295.77 | -185.46 |
Gromacs
Wildtype
Force Field | Average | Error Estimat | RMSD | Tot-Drift (kJ/mol) |
---|---|---|---|---|
Bond | ||||
AMBERGS | 1826.99 | 420 | 4409.39 | -2499.37 |
AMBER03 | 1639.74 | 410 | 4358.68 | -2424.42 |
CHARMM27 | 2908.14 | 350 | 4779.8 | -2033.44 |
Angle | ||||
AMBERGS | 5496.47 | 74 | 476.18 | 408.548 |
AMBER03 | 5324.13 | 72 | 469.75 | 369.24 |
CHARMM27 | 7975.2 | 86 | 798.12 | 432.901 |
Potential | ||||
AMBERGS | -114713 | 1200 | 5648.79 | -7915.46 |
AMBER03 | -91307.7 | 1200 | 5559.82 | -7839.05 |
CHARMM27 | 136.699 | 32 | 64.3892 | 227.896 |
Mutations
Force Field | Average | Error Estimat | RMSD | Tot/Drift |
---|---|---|---|---|
Bond | ||||
1 | 1815.39 | 570 | 5166.85 | -3384.48 |
2 | 1862.77 | 610 | 5331.85 | -3618.04 |
3 | 1773.13 | 520 | 4937.34 | -3068.93 |
4 | 1828.63 | 580 | 5229.18 | -3479.09 |
5 | 1870.95 | 610 | 5361.67 | -3713.22 |
6 | 1816.6 | 550 | 5091.81 | -3303.34 |
7 | 1819.7 | 570 | 5173.34 | -3397.07 |
8 | 2992.15 | 1700 | -nan | -10631.8 |
9 | 2083.16 | 830 | -nan | -4913.82 |
10 | 1867.42 | 620 | 5390.82 | -3693.03 |
Angle | ||||
1 | 5183.95 | 85 | 360.959 | 550.303 |
2 | 5195.33 | 80 | 364.473 | 515.645 |
3 | 5196.5 | 89 | 353.256 | 586.473 |
4 | 5175.59 | 85 | 364.496 | 547.465 |
5 | 5113.99 | 81 | 365.511 | 526.244 |
6 | 5200.44 | 85 | 356.964 | 553.934 |
7 | 5261.77 | 87 | 365.202 | 565.196 |
8 | 5178.73 | 76 | -nan | 215.036 |
9 | 5201.95 | 76 | -nan | 442.141 |
10 | 5174.48 | 88 | 375.775 | 555.294 |
Potential | ||||
1 | -90528.4 | 1600 | 7234.09 | -10149.1 |
2 | -90481.9 | 1600 | 7442.03 | -10340 |
3 | -90654 | 1500 | 6928.73 | -9614.54 |
4 | -90541 | 1600 | 7311.04 | -10343.7 |
5 | -91011.7 | 1600 | 7484.45 | -10592.5 |
6 | -90782.2 | 1600 | 7226.99 | -10188.5 |
7 | -90232.9 | 1600 | 7236.24 | -10198 |
8 | -87316 | 3600 | -nan | -23670.3 |
9 | -90090.3 | 1900 | -nan | -12335.3 |
10 | -89721.8 | 1700 | 7523.88 | -10750.1 |
Mutation | Plot |
---|---|
1 | |
2 | |
3 | |
4 | |
5 | |
6 | |
7 | |
8 | |
9 | |
10 |
References
<references />